These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 76222)

  • 1. Relation between plasma oestrone and oestradiol and climacteric symptoms.
    Hutton JD; Jacobs HS; Murray MA; James VH
    Lancet; 1978 Apr; 1(8066):678-81. PubMed ID: 76222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between the karyopyknotic index and plasma oestrogen concentrations after the menopause.
    Morse AR; Hutton JD; Jacobs HS; Murray MA; James VH
    Br J Obstet Gynaecol; 1979 Dec; 86(12):981-3. PubMed ID: 526457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of serum oestrogen concentrations in post-menopausal women taking oestrone sulphate and oestradiol.
    Anderson AB; Sklovsky E; Sayers L; Steele PA; Turnbull AC
    Br Med J; 1978 Jan; 1(6106):140-2. PubMed ID: 620226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of oestrone and oestradiol-17beta in postmenopausal women.
    Badawy SZ; Elliott LJ; Elbadawi A; Marshall LD
    Br J Obstet Gynaecol; 1979 Jan; 86(1):56-63. PubMed ID: 760768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An oestrone-releasing vaginal ring in the treatment of climacteric women.
    Sipinen S; Lähteenmäki P; Luukkainen T
    Maturitas; 1980 Dec; 2(4):291-9. PubMed ID: 7231201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The symptomatology of the climacteric in relation to hormonal and cytological factors.
    James CE; Breeson AJ; Kovacs G; Hill JG; Grant C; Allen KM; Fry DE; Baylis EM
    Br J Obstet Gynaecol; 1984 Jan; 91(1):56-62. PubMed ID: 6691946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin).
    Englund DE; Johansson ED
    Br J Obstet Gynaecol; 1978 Dec; 85(12):957-64. PubMed ID: 216384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma oestrone, oestradiol and gonadotrophin concentrations in postmenopausal patients treated with oestradiol or with a combination of oestradiol and oestriol.
    Sipinen S
    Ann Clin Res; 1979 Oct; 11(5):172-8. PubMed ID: 121048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma androstenedione and oestrone levels in the climacteric syndrome.
    Mango D; Scirpa P; Battaglia F; Bini E
    Maturitas; 1984 Apr; 5(4):245-50. PubMed ID: 6738370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of oral and transdermal oestradiol administration on oestrogen metabolism, protein synthesis, gonadotrophin release, bone turnover and climacteric symptoms in postmenopausal women.
    Selby P; McGarrigle HH; Peacock M
    Clin Endocrinol (Oxf); 1989 Mar; 30(3):241-9. PubMed ID: 2512035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S; Collins WP; Thom MH; Studd JW
    Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrone sulphate in plasma from postmenopausal women and the effects of oestrogen and androgen therapy.
    Towobola OA; Crilly RC; Oakey RE
    Clin Endocrinol (Oxf); 1980 Nov; 13(5):461-71. PubMed ID: 6261992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogen production and metabolism in peri-menopausal women.
    Reed MJ; Beranek PA; James VH
    Maturitas; 1986 Mar; 8(1):29-34. PubMed ID: 3084922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma-oestrogen and climacteric symptoms.
    Utian WH
    Lancet; 1978 May; 1(8073):1099-100. PubMed ID: 77396
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
    Schindler AE; Bolt HM; Zwirner M; Hochlehnert G; Göser R
    Arzneimittelforschung; 1982; 32(7):787-91. PubMed ID: 6289846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose oestradiol in the treatment of urogenital oestrogen deficiency--a pharmacokinetic and pharmacodynamic study.
    Nilsson K; Heimer G
    Maturitas; 1992 Oct; 15(2):121-7. PubMed ID: 1470044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum oestrone, oestradiol and oestriol levels in ovariectomized women receiving a high dose of oestradiol valerate.
    Heinonen PK; Saarikoski S; Pyykkö K; Pystynen P
    Maturitas; 1982 Dec; 4(4):273-6. PubMed ID: 7169962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal profile of endometrial cancer.
    Oettinger M; Samberg I; Levitan Z; Eibschitz I; Sharf M
    Gynecol Obstet Invest; 1984; 17(5):225-35. PubMed ID: 6735271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous estrogen levels in postmenopausal women with severe urogenital atrophy.
    Nilsson K; Heimer G
    Gynecol Obstet Invest; 1992; 34(4):234-6. PubMed ID: 1487183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal profiles after the menopause.
    Chakravarti S; Collins WP; Forecast JD; Newton JR; Oram DH; Studd JW
    Br Med J; 1976 Oct; 2(6039):784-7. PubMed ID: 974609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.